Genasys Inc.
For the period ended Dec 31, 2025. Filed Feb 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2025 · Filed Feb 10, 2026
GNSS$1.41+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Three Months EndedDecember 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Operating Activities: | ||
| Net loss | $(817) | $(4,078) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||
| Depreciation and amortization | 682 | 737 |
| Warranty provision (settlement) | 20 | (6) |
| Inventory obsolescence | 26 | 73 |
| Share-based compensation | 419 | 391 |
| Gain on change in fair value of warrants | (870) | (2,470) |
| Loss on change in fair value of Term Loans | 771 | 370 |
| Amortization of operating lease right of use asset | 205 | 192 |
| Accretion of investment of marketable securities | — | 33 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable, net | (1,287) | 259 |
| Contract assets | (1,033) | — |
| Inventories, net | 206 | (260) |
| Prepaid expenses and other | (513) | (1,084) |
| Accounts payable | (711) | 500 |
| Customer deposit | 10,636 | — |
| Accrued and other liabilities | (534) | 6,290 |
| Net cash provided by operating activities | 7,200 | 947 |
| Investing Activities: | ||
| Purchases of marketable securities | — | (1,400) |
| Proceeds from maturities of marketable securities | 41 | 4,102 |
| Capital expenditures | — | (69) |
| Net cash provided by investing activities | 41 | 2,633 |
| Financing Activities: | ||
| Proceeds from exercise of stock options | 34 | 1 |
| Repayment of First Amendment Term Loan principal | (4,000) | — |
| Payment of minimum return on First Amendment Term Loan | (961) | — |
| Shares retained for payment of taxes in connection with exercise of stock options | (2) | — |
| Net cash (used in) provided by financing activities | (4,929) | 1 |
| Effect of foreign exchange rate on cash | 5 | (55) |
| Net increase in cash, cash equivalents, and restricted cash | 2,317 | 3,526 |
| Cash, cash equivalents and restricted cash, beginning of period | 8,554 | 5,288 |
| Cash, cash equivalents and restricted cash, end of period | $10,871 | $8,814 |
| Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets: | ||
| Cash and cash equivalents | $10,286 | $8,469 |
| Restricted cash, current portion | — | 95 |
| Long-term restricted cash | 585 | 250 |
| Total cash, cash equivalents and restricted cash shown in the consolidated balance sheets | $10,871 | $8,814 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
| Three Months EndedDecember 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Noncash investing and financing activities: | ||
| Change in unrealized gain on marketable securities | $— | $7 |
| Purchases of property and equipment included in accounts payable and accrued liabilities | $— | $3 |
| Supplemental disclosure of cash flow information | ||
| Cash paid for interest | $435 | $368 |
| Cash paid for taxes | $109 | $11 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.